PTC Therapeutics Inc (PTCT)
43.22
+0.33
(+0.77%)
USD |
NASDAQ |
Nov 22, 16:00
43.23
+0.01
(+0.02%)
After-Hours: 16:00
PTC Therapeutics Shareholders Equity (Quarterly): -1.054B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -1.054B |
June 30, 2024 | -980.18M |
March 31, 2024 | -893.92M |
December 31, 2023 | -818.56M |
September 30, 2023 | -670.81M |
June 30, 2023 | -579.27M |
March 31, 2023 | -457.56M |
December 31, 2022 | -347.09M |
September 30, 2022 | -226.90M |
June 30, 2022 | -182.22M |
March 31, 2022 | -90.58M |
December 31, 2021 | 1.438M |
September 30, 2021 | 104.93M |
June 30, 2021 | 196.58M |
March 31, 2021 | 292.58M |
December 31, 2020 | 481.98M |
September 30, 2020 | 510.95M |
June 30, 2020 | 572.49M |
March 31, 2020 | 528.73M |
December 31, 2019 | 594.33M |
September 30, 2019 | 663.65M |
June 30, 2019 | 488.68M |
March 31, 2019 | 512.94M |
December 31, 2018 | 350.73M |
Date | Value |
---|---|
September 30, 2018 | 386.09M |
June 30, 2018 | 267.40M |
March 31, 2018 | 150.31M |
December 31, 2017 | 156.44M |
September 30, 2017 | 145.88M |
June 30, 2017 | 169.73M |
March 31, 2017 | 100.83M |
December 31, 2016 | 119.58M |
September 30, 2016 | 140.18M |
June 30, 2016 | 165.62M |
March 31, 2016 | 196.00M |
December 31, 2015 | 226.00M |
September 30, 2015 | 269.15M |
June 30, 2015 | 248.58M |
March 31, 2015 | 273.32M |
December 31, 2014 | 298.47M |
September 30, 2014 | 201.30M |
June 30, 2014 | 223.76M |
March 31, 2014 | 244.34M |
December 31, 2013 | 136.54M |
September 30, 2013 | 151.03M |
June 30, 2013 | 152.92M |
March 31, 2013 | 34.08M |
December 31, 2012 | -19.19M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.054B
Minimum
Sep 2024
594.33M
Maximum
Dec 2019
-150.87M
Average
-136.40M
Median
Shareholders Equity (Quarterly) Benchmarks
ClearPoint Neuro Inc | 29.00M |
Pfizer Inc | 92.29B |
Vertex Pharmaceuticals Inc | 15.63B |
BridgeBio Pharma Inc | -1.230B |
Cassava Sciences Inc | 166.64M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.842B |
Total Liabilities (Quarterly) | 2.897B |
Debt to Equity Ratio | -0.2704 |
Current Ratio | 2.098 |
Net Debt Paydown Yield | 2.01% |